“clinical-trials” Archives

in
Entry Author Date Location
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
First Trial in Sight, Editas Cuts $90M Eye Drug Deal With Allergan 03/14/17 Boston
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
Seattle Genetics to Resume Leukemia Drug Trials After FDA Lifts Hold 03/06/17 Seattle
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
Ingeneron Gets $20M From Sanford Health For Stem Cell Treatment 03/06/17 Texas
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
No Details Yet, But Genentech Drug Combo Wins in Big Breast Cancer Study 03/02/17 San Francisco
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Former FDA Commissioners Califf, McClellan Talk Healthcare’s Future 03/01/17 National
FDA Approves Houston Biotech Lexicon’s Carcinoid Syndrome Diarrhea Drug 02/28/17 Texas
Blood Pressure Drug Trial Results Lift La Jolla Pharma Shares 02/27/17 San Diego
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy 02/27/17 New York
Cempra Soars on Drug’s Potential to Treat MRSA, Other Infections 02/24/17 Raleigh Durham
Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M 02/22/17 New York
Cidara Antifungal Flunks in Phase 2 Clinical Trial, Sinking Shares 02/21/17 San Diego
After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future 02/21/17 Wisconsin
His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? 02/16/17 New York
With $20M, UCSD Spinout Jecure To Press New Attack On NASH 02/15/17 San Diego
FDA Turmoil, Biology Mystery On List Of Hurdles For Microbiome Drugs 02/14/17 New York
Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation 02/10/17 National
Acorda Touts Success in Parkinson’s Drug Study, Awaits Safety Data 02/09/17 New York
No Details Yet, But Amgen Touts Success in Big Heart Drug Study 02/02/17 San Francisco
Tarveda Nabs $30M More as Versant Helps Fund Cancer Drug Push 02/02/17 Boston
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
Investors Sour on Data Debut For Dimension’s Hemophilia Gene Therapy 01/31/17 Boston
Seres Dissects Failed Microbiome Drug Trial, Suggests Changes to FDA 01/31/17 Boston
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits 01/30/17 San Francisco
Novan Acne Drug Hits Targets in One Late-Stage Trial, Fails Another 01/27/17 Raleigh Durham
Jounce Gets $102M As Biotech IPOs Gain Steam in ’17 01/27/17 Boston
Page 3 of 24 « previous page · next page »